Cargando…
Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer
Patient: Female, 51 Final Diagnosis: Ewing sarcoma Symptoms: Visual disturbances Medication: — Clinical Procedure: — Specialty: Oncology OBJECTIVE: Rare disease BACKGROUND: Primitive neuroectodermal tumor/Ewing sarcoma (PNET/EWS) is a round blue cell sarcoma that shows varying degrees of neuroectode...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102603/ https://www.ncbi.nlm.nih.gov/pubmed/25045413 http://dx.doi.org/10.12659/AJCR.890656 |
_version_ | 1782327042344222720 |
---|---|
author | Cole, Marion Parajuli, Shobha Laske, Douglas Goldstein, Lori Morrison, Tara Mukherjee, Abir Tumelty, Kathryn Tetzlaff, Eric von Mehren, Margaret Inniss, Susan |
author_facet | Cole, Marion Parajuli, Shobha Laske, Douglas Goldstein, Lori Morrison, Tara Mukherjee, Abir Tumelty, Kathryn Tetzlaff, Eric von Mehren, Margaret Inniss, Susan |
author_sort | Cole, Marion |
collection | PubMed |
description | Patient: Female, 51 Final Diagnosis: Ewing sarcoma Symptoms: Visual disturbances Medication: — Clinical Procedure: — Specialty: Oncology OBJECTIVE: Rare disease BACKGROUND: Primitive neuroectodermal tumor/Ewing sarcoma (PNET/EWS) is a round blue cell sarcoma that shows varying degrees of neuroectodermal differentiation. PNET/EWS as a primary intracranial tumor is extremely uncommon. CASE REPORT: We report a unique case of peripheral PNET presenting as an intracranial mass in an adult following chemotherapy and radiotherapy for a solid tumor. A 51-year-old woman with previously treated left breast cancer was evaluated for a newly developed brain mass. She underwent craniotomy with resection. Surgical pathology was consistent with a peripheral PNET/EWS with Ewing sarcoma gene translocation. She was treated appropriately with vincristine, cyclophosphamide, and doxorubicin (later dactinomycin) alternating with ifosfamide and etoposide. CONCLUSIONS: Although development of PNET/EWS presenting along the CNS is exceedingly rare in adults, establishing the proper diagnosis of this “small blue cell tumor” is critical. The further distinction between central PNET and peripheral PNET can greatly impact both prognosis and treatment. Our case also highlights the importance of considering the impact of prior intensive therapies, including radiation and chemotherapy, on predisposing to future PNET/EWS. |
format | Online Article Text |
id | pubmed-4102603 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-41026032014-07-18 Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer Cole, Marion Parajuli, Shobha Laske, Douglas Goldstein, Lori Morrison, Tara Mukherjee, Abir Tumelty, Kathryn Tetzlaff, Eric von Mehren, Margaret Inniss, Susan Am J Case Rep Articles Patient: Female, 51 Final Diagnosis: Ewing sarcoma Symptoms: Visual disturbances Medication: — Clinical Procedure: — Specialty: Oncology OBJECTIVE: Rare disease BACKGROUND: Primitive neuroectodermal tumor/Ewing sarcoma (PNET/EWS) is a round blue cell sarcoma that shows varying degrees of neuroectodermal differentiation. PNET/EWS as a primary intracranial tumor is extremely uncommon. CASE REPORT: We report a unique case of peripheral PNET presenting as an intracranial mass in an adult following chemotherapy and radiotherapy for a solid tumor. A 51-year-old woman with previously treated left breast cancer was evaluated for a newly developed brain mass. She underwent craniotomy with resection. Surgical pathology was consistent with a peripheral PNET/EWS with Ewing sarcoma gene translocation. She was treated appropriately with vincristine, cyclophosphamide, and doxorubicin (later dactinomycin) alternating with ifosfamide and etoposide. CONCLUSIONS: Although development of PNET/EWS presenting along the CNS is exceedingly rare in adults, establishing the proper diagnosis of this “small blue cell tumor” is critical. The further distinction between central PNET and peripheral PNET can greatly impact both prognosis and treatment. Our case also highlights the importance of considering the impact of prior intensive therapies, including radiation and chemotherapy, on predisposing to future PNET/EWS. International Scientific Literature, Inc. 2014-07-10 /pmc/articles/PMC4102603/ /pubmed/25045413 http://dx.doi.org/10.12659/AJCR.890656 Text en © Am J Case Rep, 2014 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License |
spellingShingle | Articles Cole, Marion Parajuli, Shobha Laske, Douglas Goldstein, Lori Morrison, Tara Mukherjee, Abir Tumelty, Kathryn Tetzlaff, Eric von Mehren, Margaret Inniss, Susan Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer |
title | Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer |
title_full | Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer |
title_fullStr | Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer |
title_full_unstemmed | Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer |
title_short | Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer |
title_sort | peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102603/ https://www.ncbi.nlm.nih.gov/pubmed/25045413 http://dx.doi.org/10.12659/AJCR.890656 |
work_keys_str_mv | AT colemarion peripheralprimitiveneuroectodermaltumoroftheduraina51yearoldwomanfollowingintensivetreatmentforbreastcancer AT parajulishobha peripheralprimitiveneuroectodermaltumoroftheduraina51yearoldwomanfollowingintensivetreatmentforbreastcancer AT laskedouglas peripheralprimitiveneuroectodermaltumoroftheduraina51yearoldwomanfollowingintensivetreatmentforbreastcancer AT goldsteinlori peripheralprimitiveneuroectodermaltumoroftheduraina51yearoldwomanfollowingintensivetreatmentforbreastcancer AT morrisontara peripheralprimitiveneuroectodermaltumoroftheduraina51yearoldwomanfollowingintensivetreatmentforbreastcancer AT mukherjeeabir peripheralprimitiveneuroectodermaltumoroftheduraina51yearoldwomanfollowingintensivetreatmentforbreastcancer AT tumeltykathryn peripheralprimitiveneuroectodermaltumoroftheduraina51yearoldwomanfollowingintensivetreatmentforbreastcancer AT tetzlafferic peripheralprimitiveneuroectodermaltumoroftheduraina51yearoldwomanfollowingintensivetreatmentforbreastcancer AT vonmehrenmargaret peripheralprimitiveneuroectodermaltumoroftheduraina51yearoldwomanfollowingintensivetreatmentforbreastcancer AT innisssusan peripheralprimitiveneuroectodermaltumoroftheduraina51yearoldwomanfollowingintensivetreatmentforbreastcancer |